GRAL

#1890
GRAIL, Inc. Common Stock
52.0800 USD
-5.34%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
51.9250
52.6900
Rango anual
41.5000
102.5200
Cambio diario
-5.34%
Variación mensual
+6.29%
Variación en los últimos 6 meses
-47.39%
Cambio anual
-47.39%
Cierres anteriores
55.0200
Abrir
52.2550
Mínimo
51.9250
High
52.6900
Volumen
107
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor 20242025 TTM

GRAIL Inc

GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021. In June 2021 GRAIL launched their liquid biopsy, or multi-cancer early detection test, which they called Galleri test. In 2023 EU regulators ordered Grail to be spun-out from Illumina which was completed on June 24, 2024.